These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2977396)

  • 41. Randomised trial of SIR-Spheres plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer.
    Gray B; Van Hazel G; Hope M; Burton M; Moroz P; Anderson J; Gebski V
    Ann Oncol; 2001 Dec; 12(12):1711-20. PubMed ID: 11843249
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Circulating tumor marker levels in advanced breast carcinoma correlate with the extent of metastatic disease.
    Colomer R; Ruibal A; Salvador L
    Cancer; 1989 Oct; 64(8):1674-81. PubMed ID: 2790682
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of CA-242 and CEA in surveillance following curative resection for colorectal cancer.
    Hall NR; Finan PJ; Stephenson BM; Purves DA; Cooper EH
    Br J Cancer; 1994 Sep; 70(3):549-53. PubMed ID: 8080745
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The significance of CEA, CA19-9 and CA72-4 in the detection of colorectal carcinoma recurrence.
    Holubec L; Topolcan O; Pikner R; Pecen L; Vaclavickova J; Wirthova M; Molacek J; Stieber P; Holdenrieder S; Sen LH; Finek J
    Anticancer Res; 2000; 20(6D):5237-44. PubMed ID: 11326702
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer.
    Chau I; Allen MJ; Cunningham D; Norman AR; Brown G; Ford HE; Tebbutt N; Tait D; Hill M; Ross PJ; Oates J
    J Clin Oncol; 2004 Apr; 22(8):1420-9. PubMed ID: 15007086
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The value of tumor volumetry as opposed to bidimensional determination of tumor size during follow-up of hepatic metastases from colorectal carcinoma].
    Pfeifer T; Häussler MD; Tomczak R; Rilinger N; Zeitler H; Laasch HU; Friedrich JM; Safi F
    Rofo; 1992 Dec; 157(6):548-51. PubMed ID: 1457789
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial.
    Kemeny N; Daly J; Reichman B; Geller N; Botet J; Oderman P
    Ann Intern Med; 1987 Oct; 107(4):459-65. PubMed ID: 2957943
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Carcinoembryonic antigen and breast carcinoma antigen (CA 15.3) in preoperative staging and postoperative monitoring of patients with carcinoma of the breast.
    Omar YT; Behbehani AE; al-Naqeeb N; Motawy MM; Folldi MO; Awwad AH; Nasralla MY; Szymendera JJ
    Int J Biol Markers; 1988; 3(3):165-71. PubMed ID: 3230336
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer.
    Kemeny N; Seiter K; Niedzwiecki D; Chapman D; Sigurdson E; Cohen A; Botet J; Oderman P; Murray P
    Cancer; 1992 Jan; 69(2):327-34. PubMed ID: 1303612
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Unresectable hepatic metastases from carcinoma of the colon and rectum.
    Didolkar MS; Elias EG; Whitley NO; Keramati B; Jackson AJ; Hebel RJ; Jordan TE
    Surg Gynecol Obstet; 1985 May; 160(5):429-36. PubMed ID: 3992446
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Extrahepatic biliary stenoses after hepatic arterial infusion (HAI) of floxuridine (FUdR) for liver metastases from colorectal cancer.
    Aldrighetti L; Arru M; Ronzoni M; Salvioni M; Villa E; Ferla G
    Hepatogastroenterology; 2001; 48(41):1302-7. PubMed ID: 11677951
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatic cryotherapy and regional chemotherapy with or without resection for liver metastases from colorectal carcinoma: how many are too many?
    Yan DB; Clingan P; Morris DL
    Cancer; 2003 Jul; 98(2):320-30. PubMed ID: 12872352
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluating the significance of expression of CEA mRNA and levels of CEA and its related proteins in colorectal cancer patients.
    Wang W; Li Y; Zhang X; Jing J; Zhao X; Wang Y; Han C
    J Surg Oncol; 2014 Apr; 109(5):440-4. PubMed ID: 24783267
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Occurrence of carcinoma-associated antigen 494 in colorectal cancer tissue and in Patients' sera during metastatic disease.
    Lindhorst E
    Tumour Biol; 2000; 21(2):116-22. PubMed ID: 10686541
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CA 125: a clinically useful tumor marker in the management of colorectal carcinoma metastatic to the liver in patients with normal carcinoembryonic antigen.
    Mavligit GM; Estrov Z
    Am J Clin Oncol; 2000 Apr; 23(2):213-5. PubMed ID: 10776987
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Does CEA and CA 19-9 combined increase the likelihood of 18F-FDG in detecting recurrence in colorectal patients with negative CeCT?
    Panagiotidis E; Datseris IE; Rondogianni P; Vlontzou E; Skilakaki M; Exarhos D; Bamias A
    Nucl Med Commun; 2014 Jun; 35(6):598-605. PubMed ID: 24681767
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The pre- and postoperative monitoring of the immunological indices and tumor markers in colorectal carcinoma].
    Iarŭmov N; Ignatov A; Viiachki I
    Khirurgiia (Sofiia); 1998; 51(3):42-8. PubMed ID: 9974027
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A prospective study of continuous hepatic perfusion with implantable pump.
    Riether RD; Khubchandani IT; Sheets JA; Stasik JJ; Rosen L
    Dis Colon Rectum; 1985 Jan; 28(1):24-6. PubMed ID: 3156027
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Clinical significance of serum NCC-ST 439 as a tumor marker for colorectal cancer].
    Yamaguchi A; Kurosaka Y; Ohta N; Kamata T; Ishida T; Nishimura G; Katoh M; Kosaka T; Yonemura Y; Miyazaki I
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2645-50. PubMed ID: 2549882
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Post-chemotherapeutic CEA and CA19-9 are prognostic factors in patients with colorectal liver metastases treated with hepatic resection after oxaliplatin-based chemotherapy.
    Sakamoto Y; Miyamoto Y; Beppu T; Nitta H; Imai K; Hayashi H; Baba Y; Yoshida N; Chikamoto A; Baba H
    Anticancer Res; 2015 Apr; 35(4):2359-68. PubMed ID: 25862901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.